Showing 1 - 4 results of 4 for search 'Isabelle Bourgault-Villada', query time: 0.03s Refine Results
  1. 1
    Arthritis Caused by Nannizziopsis obscura, France

    Arthritis Caused by Nannizziopsis obscura, France by Hélène Mascitti, Valérie Sivadon-Tardy, Marie-Elisabeth Bougnoux, Clara Duran, Mickael Tordjman, Marie-Alice Colombier, Isabelle Bourgault-Villada, Aurélien Dinh

    Published 2022-09-01
    Get full text
    Article
  2. 2
    Anti-HPV16 E2 protein T-cell responses and viral control in women with usual vulvar intraepithelial neoplasia and their healthy partners.

    Anti-HPV16 E2 protein T-cell responses and viral control in women with usual vulvar intraepithelial neoplasia and their healthy partners. by Simon Jacobelli, Fedoua Sanaa, Micheline Moyal-Barracco, Monique Pelisse, Sophie Berville, Pascale Villefroy, Marie Odile North, Suzanne Figueiredo, Bénédicte Charmeteau, Thierry Clerici, Françoise Plantier, Françoise Arnold, Antoine Touzé, Nicolas Dupin, Marie-Françoise Avril, Jean-Gérard Guillet, Rémi Cheynier, Isabelle Bourgault-Villada

    Published 2012-01-01
    Get full text
    Article
  3. 3
    Higher prevalence of splenic artery aneurysms in hereditary hemorrhagic telangiectasia: Vascular implications and risk factors.

    Higher prevalence of splenic artery aneurysms in hereditary hemorrhagic telangiectasia: Vascular implications and risk factors. by Jacques Sellier, Carma Karam, Alain Beauchet, Axel Dallongeville, Stephen Binsse, Sandra Blivet, Isabelle Bourgault-Villada, Philippe Charron, Thierry Chinet, Mélanie Eyries, Carole Fagnou, Jérome Lesniak, Gilles Lesur, Jérome Lucas, Agnès Nicod-Tran, Augustin Ozanne, Aurélien Palmyre, Florent Soubrier, Mostafa El Hajjam, Pascal Lacombe

    Published 2020-01-01
    Get full text
    Article
  4. 4
    Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial.

    Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial. by Odile Launay, Christine Durier, Corinne Desaint, Benjamin Silbermann, Angela Jackson, Gilles Pialoux, Bénédicte Bonnet, Isabelle Poizot-Martin, Gustavo Gonzalez-Canali, Lise Cuzin, Suzanne Figuereido, Mathieu Surenaud, Nadine Ben Hamouda, Hanne Gahery, Jeannine Choppin, Dominique Salmon, Corinne Guérin, Isabelle Bourgault Villada, Jean-Gérard Guillet, ANRS VAC16 Study Group

    Published 2007-08-01
    Get full text
    Article

Search Tools: